CD BioGlyco Released Characterization Service of Glycosylation in Protein Drugs
CD BioGlyco, a leader in glycosylation characterization, recently developed a comprehensive glycoproteomics platform to provide its customers worldwide with the characterization of glycosylation in protein drugs.   Glycoproteins, such as glycosyltransferases, glycosidases, erythropoietin, and cytokines, make up the majority of biotherapeutic products. Although the drugs themselves are...
0 Comments 0 Shares 813 Views 0 Reviews